A patient who has cystic fibrosis has a Pseudomonas aeruginosa infection and the provider has ordered aztreonam [Cayston]. What will the nurse teach this patient about administration of this drug?

Question

Quizplus · Accepted Answer

Cayston is a form of aztreonam formulated for inhalation administration for patients with cystic fibrosis who have P. aeruginosa lung infections. The reconstituted powder is given using a nebulizer system 3 times daily for 28 days followed by 28 days off. This form of the drug is not given IM. The dose is 3 times daily. The drug is reconstituted and administered via a nebulizer.

A Patient Who Has Cystic Fibrosis Has a Pseudomonas Aeruginosa